Saturday Rounds: Week of October 17–23, 2026

A cure endpoint, a rebound, and milestone-heavy deals. Weekly Biotech Signal Review · Completed reporting week: October 17–October 23, 2026 · Published October 24, 2026 Report at a glance: The FDA approved the first antisense drug for chronic hepatitis B on a functional-cure endpoint, XBI…